This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.
A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell. Their findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.
“This study presents results from an unprecedented international collaboration and demonstrates how 43 previously competing labs can together accelerate therapeutics and vaccine design,” says Erica Ollmann Saphire, PhD, professor at Scripps Research and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC).
From 2013–2016, West Africa faced the deadliest Ebola outbreak the world has ever seen. By the time the outbreak was declared over, 11,325 people had died. The VIC is an international group of the world’s leading virologists, immunologists, systems biologists and structural biologists working to stop an outbreak on that scale from ever striking again.
The VIC researchers aim to understand which Ebola-fighting antibodies are best—and why. The hope is that the most effective antibodies can be combined in a therapeutic “cocktail.” Unlike an Ebola vaccine, these cocktails could be given to those already infected, which is important for stopping a disease that tends to emerge unexpectedly in remote locations.
Ollmann Saphire and her colleagues in the VIC have published more than 40 studies in just the last five years. This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus and other related viruses, known as filoviruses. All antibodies in the panel were donated by different labs around the world, and many had not been previously characterized in such extensive detail.
“Through the VIC, we could test a larger pool of antibodies in parallel, which increased the potential to detect statistically significant relationships between antibody features and protection,” says Saphire. “We used this global pool of antibodies to evaluate, and streamline, the research pipeline itself.”
In addition to identifying links between antibody target locations and activity, VIC researchers tested this huge pool of antibodies to reveal which antibodies “neutralized” the virus, why neutralization assays so often disagree, and whether or not neutralization in test tubes adequately predicted how well these antibodies would protect live animals from Ebola virus infection. Unexpectedly, neutralization alone was not always associated with the protective ability of an antibody.
Notably, the scientists found nine antibodies that protected mice from infection without neutralizing the virus in test tubes. These antibodies likely fight infection by interacting with an infected person’s immune system, helping orchestrate a better immune response to the virus.
This “immune effector” activity is featured in the team’s companion study published simultaneously in Cell Host & Microbe. “The ability to evoke an immune response will likely represent a new avenue of study for therapeutic antibodies for Ebola virus infection,” says Sharon Schendel, project manager for the VIC and science writer in the Saphire lab.
From the large body of results, VIC member and Scripps Research faculty member Kristian Andersen, PhD, and his graduate student Karthik Gangavarapu developed a network describing how each antibody feature correlates to protection, which can serve as a guide to predict whether newly identified antibodies will have therapeutic value. Saphire says the next steps for the VIC are to further test promising antibody cocktails in non-human primates. The team will also pursue engineering of antibodies that carry signature features to better drive immune system response.
The Latest on: Ebola
via Google News
The Latest on: Ebola
Tackling Ebola in Congo conflict zone an 'unprecedented' challenge
on August 17, 2018 at 10:33 am
DAKAR, Aug 17 (Thomson Reuters Foundation) - A deadly Ebola outbreak in a conflict-hit area of the Democratic Republic of Congo poses an “unprecedented” challenge to health workers trying to access vi... […]
Antibodies Could Knock Out Ebola Virus
on August 17, 2018 at 10:02 am
In 1995, a patient sick with the Ebola virus, in what was then called Zaire and is now the Democratic Republic of the Congo, miraculously recovered from this deadly disease. At that time, when the vir... […]
Militia threat hampers Ebola fight in Congo as disease kills 44
on August 17, 2018 at 9:09 am
GENEVA (Reuters) - Militia violence in Democratic Republic of Congo has prevented aid workers from reaching some potential cases in an outbreak of Ebola that has so far killed 44 people, the World Hea... […]
Congo’s new Ebola outbreak is hitting health care workers hard
on August 17, 2018 at 9:00 am
Health care workers have been especially hard hit by the current outbreak of Ebola in the northeastern part of the Democratic Republic of the Congo (DRC). To date, nine of the 51 confirmed cases of Eb... […]
Security Issues Constrain DR Congo Ebola Operation
on August 17, 2018 at 8:35 am
The World Health Organization says security issues could hamper efforts to contain an Ebola outbreak in the eastern Democratic Republic of Congo. The outbreak is in conflict-ridden North Kivu province ... […]
Ebola cases in DR Congo rise to 78, 44 dead
on August 17, 2018 at 8:08 am
Seventy-eight cases of Ebola have been recorded in an outbreak in northeast Democratic Republic of Congo, claiming 44 lives, DRC officials and the World Health Organization (WHO) said Friday. The late... […]
WHO expects more Ebola cases in Congo, can't reach no-go areas
on August 17, 2018 at 6:25 am
GENEVA, Aug 17 (Reuters) - The World Health Organization (WHO) said on Friday that it could not be certain that it had identified all people exposed to the deadly Ebola virus in the Democratic Republi... […]
WHO Expects Ebola To Spread In Congo In Areas Too Dangerous To Send Workers
on August 17, 2018 at 4:55 am
The World Health Organization said Friday that security concerns in the Democratic Republic of the Congo's North Kivu region were preventing aid workers from reaching certain areas — and leaving open ... […]
Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure
on August 17, 2018 at 4:46 am
ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that it was awarded an Other Transaction Agreement (OTA ... […]
via Bing News